International Health Partners Urges Integrated Approach To Donations And CSR
Working With Companies To Help Build CSR Activities Into Strategy
Executive Summary
Generics firms are increasingly adopting a more integrated approach to corporate social responsibility activities, including product donations, as part of their strategy as they work alongside organizations such as International Health Partners, the charity’s CEO Adele Paterson tells Generics Bulletin.
You may also be interested in...
Accord Takes A Trio Of Awards
Accord Healthcare took home a trio of prizes at the Global Generics & Biosimilars Awards 2020, with other winners including Alvogen, Aurobindo, Dr Reddy’s, Eurofarma, Insud Pharma, Macleods, Pinsent Masons, Samsung Bioepis, Sandoz, Stada and Zentiva.
Action Needed To Prevent Post-Brexit Catastrophe In Northern Ireland
Action is needed from both the UK government and the European Commission to prevent a collapse of Northern Ireland’s generics market, according to the BGMA.
PlantForm Strikes Deal For Brazilian Pembrolizumab
Canada’s PlantForm has struck a deal with Brazil’s Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab rival to Merck’s Keytruda for the Brazilian market and potentially beyond.